Novovax, a Gaithersburg, Md.-based biotech company, says the coronavirus vaccine it is developing has shown signs of effectiveness against new, more contagious variants of the virus.
Novovax, a Gaithersburg, Md.-based biotech company, says the coronavirus vaccine it is developing has shown signs of effectiveness against new, more contagious variants of the virus.

Be the first to know: Stories from The Washington Informer in your inbox each weekday.
We'll send a verification code to %EMAIL%.
Get the best of The Washington Informer directly in your email inbox.
Sending to: